Latest Articles

Publication Date
A Chemo-Free Option for Some Advanced Endometrial Cancers? - Medscape

A Chemo-Free Option for Some Advanced Endometrial Cancers? Medscape

Published: April 17, 2026, 11:26 a.m.
The impact of endocrine-disrupting chemicals on uterine diseases.

Endocrine-disrupting chemicals (EDCs) are a global concern for human health and the environment. EDCs include plasticizers, pharmaceutical agents, industrial chemicals, fungicides, and pesticides. Thus, EDC exposure is a manmade consequence …

Published: April 17, 2026, midnight
Novel insights into the role of Annexin A2 signaling pathway in female reproductive system diseases: from mechanisms to advanced therapies.

Annexin A2 (ANXA2) is a calcium-dependent protein with high affinity for phospholipids, and its multifunctional nature has drawn increasing attention in the onset and progression of various disorders of the …

Published: April 14, 2026, midnight
Unravelling Multilayered RNA Modification Networks in Female Reproduction and Obstetric/Gynaecologic Disorders.

Background/Objective: RNA modifications, including N6-methyladenosine (m6A), 5-methylcytosine (m5C), 7-methylguanosine (m7G), N1-methyladenosine (m1A), pseudouridine (Ψ), N4-acetylcytidine (ac4C), 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) and adenosine-to-inosine (A-to-I) editing, constitute a critical layer of post-transcriptional regulation that …

Published: April 13, 2026, midnight
GSK presents positive data for B7-H4-targeted ADC in gynecological cancers - GSK US

GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK US

Published: April 12, 2026, 2:25 p.m.
GSK presents positive data for B7-H4-targeted ADC in gynecological cancers - GSK

GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK

Published: April 12, 2026, 2:25 p.m.
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers - National Today

Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers National Today

Published: April 10, 2026, 4:35 p.m.
CSF3R signalling beyond granulopoiesis: new paradigms in female reproductive biology.

The Colony-Stimulating Factor 3 Receptor (CSF3R), the receptor for granulocyte colony-stimulating factor (G-CSF), has expanded from a hematopoietic regulator to a multifunctional signalling molecule with significant relevance in gynaecological biology. …

Published: April 7, 2026, midnight
NEWS: AI Detects More Breast Cancers in Large Screening Study - Practice Business

NEWS: AI Detects More Breast Cancers in Large Screening Study Practice Business

Published: March 16, 2026, 6:31 a.m.
Experts highlight role of multidisciplinary cancer care in managing endometrial cancers - The Hindu

Experts highlight role of multidisciplinary cancer care in managing endometrial cancers The Hindu

Published: March 6, 2026, 4:27 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!